Jane Street’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$72K Buy
5,295
+987
+23% +$14.5K ﹤0.01% 10788
2026
Q2
$66.8K Buy
+4,308
New +$47.6K ﹤0.01% 10806
2026
Q1
– Sell
-1,198
Closed -$12.7K – 12240
2025
Q4
$12.7K Buy
+1,198
New +$19.9K ﹤0.01% 10803

Other funds holding MTRI

Jane Street's MTRI Position: Q3 2026 in Review

Jane Street increased its Mentari Therapeutics, Inc. Common Stock (MTRI) stake by 23% in Q3 2026, buying an estimated $14.5K and bringing the position to 5,295 shares worth $72K. The position accounts for ﹤0.01% of the portfolio, ranked #10788.

Jane Street first reported a position in MTRI in Q4 2025 and has held it in 3 quarters since. 16 funds tracked by Wall St. Rank hold MTRI as of Q3 2026.

  • Jane Street held 5,295 shares of Mentari Therapeutics, Inc. Common Stock worth $72K as of Q3 2026.
  • Jane Street bought 987 Mentari Therapeutics, Inc. Common Stock shares in Q3 2026, an estimated $14.5K.
  • Mentari Therapeutics, Inc. Common Stock made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #10788 holding.
  • Jane Street first reported a position in Mentari Therapeutics, Inc. Common Stock in Q4 2025 and has held it in 3 quarters since.
  • 16 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.